Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Receivables - Other: 2016-2018

Historic Receivables - Other for Organogenesis Holdings (ORGO) over the last 2 years, with Sep 2018 value amounting to $250,000.

  • Organogenesis Holdings' Receivables - Other changed negligibly% to $250,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $250,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $250,000 for FY2017, which is negligibly% changed negligibly from last year.
  • Organogenesis Holdings' Receivables - Other amounted to $250,000 in Q3 2018, which was down 0.00% from $250,000 recorded in Q2 2018.
  • Organogenesis Holdings' 5-year Receivables - Other high stood at $250,000 for Q3 2016, and its period low was $250,000 during Q3 2016.
  • Over the past 3 years, Organogenesis Holdings' median Receivables - Other value was $250,000 (recorded in 2018), while the average stood at $250,000.